Article Text

Download PDFPDF
Sexually transmitted infection in HIV-positive men with erectile dysfunction using phosphodiesterase-5 inhibitors
  1. E J McCarty,
  2. K Quinn,
  3. W W Dinsmore
  1. Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK
  1. Correspondence to Dr Emma J McCarty, Department of Genitourinary Medicine, Royal Victoria Hospital, Belfast, UK; ej_mccarty{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

HIV-positive men are commonly prescribed phosphodiesterase-5 (PDE5) inhibitors for erectile dysfunction (ED). When prescribing, consideration should be given to possible onward transmission of HIV, which is enhanced by the presence of other sexually transmitted infections (STIs).1–3 We were unable to find any reports of STI acquisition in men with HIV using PDE5 inhibitors.

The aim was to audit the management of ED within our HIV cohort in Belfast according to British Society of Sexual Medicine guidelines.4 Documentation of STI diagnoses and safer sex discussion was also reviewed in …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.